Morphic Holding Performance
The company secures a Beta (Market Risk) of -0.9, which conveys possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Morphic Holding are expected to decrease slowly. On the other hand, during market turmoil, Morphic Holding is expected to outperform it slightly. Morphic Holding right now secures a risk of 0.0%. Please verify Morphic Holding variance, value at risk, as well as the relationship between the Value At Risk and skewness , to decide if Morphic Holding will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Morphic Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Morphic Holding is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 59.8 M |
Morphic |
Morphic Holding Relative Risk vs. Return Landscape
If you would invest (100.00) in Morphic Holding on September 14, 2024 and sell it today you would earn a total of 100.00 from holding Morphic Holding or generate -100.0% return on investment over 90 days. Morphic Holding is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Morphic, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Morphic Holding Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Morphic Holding's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Morphic Holding, and traders can use it to determine the average amount a Morphic Holding's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MORF |
Based on monthly moving average Morphic Holding is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Morphic Holding by adding Morphic Holding to a well-diversified portfolio.
Morphic Holding Fundamentals Growth
Morphic Stock prices reflect investors' perceptions of the future prospects and financial health of Morphic Holding, and Morphic Holding fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Morphic Stock performance.
| Return On Equity | -0.27 | |||
| Return On Asset | -0.19 | |||
| Current Valuation | 2.24 B | |||
| Shares Outstanding | 50.22 M | |||
| Price To Earning | (6.19) X | |||
| Price To Book | 4.63 X | |||
| Price To Sales | 2,753 X | |||
| Revenue | 521 K | |||
| EBITDA | (177.59 M) | |||
| Cash And Equivalents | 397.56 M | |||
| Cash Per Share | 10.33 X | |||
| Total Debt | 2.34 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 12.34 X | |||
| Cash Flow From Operations | (112.31 M) | |||
| Earnings Per Share | (3.83) X | |||
| Total Asset | 722.51 M | |||
| Retained Earnings | (449.19 M) | |||
| Current Asset | 215.41 M | |||
| Current Liabilities | 32.65 M | |||
About Morphic Holding Performance
By analyzing Morphic Holding's fundamental ratios, stakeholders can gain valuable insights into Morphic Holding's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Morphic Holding has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Morphic Holding has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Morphic Holding operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.Things to note about Morphic Holding performance evaluation
Checking the ongoing alerts about Morphic Holding for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Morphic Holding help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Morphic Holding is not yet fully synchronised with the market data | |
| Morphic Holding has some characteristics of a very speculative penny stock | |
| Morphic Holding has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 521 K. Net Loss for the year was (152.09 M) with loss before overhead, payroll, taxes, and interest of (31.25 M). | |
| Morphic Holding currently holds about 397.56 M in cash with (112.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.33. | |
| Over 91.0% of the company shares are owned by institutional investors |
- Analyzing Morphic Holding's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Morphic Holding's stock is overvalued or undervalued compared to its peers.
- Examining Morphic Holding's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Morphic Holding's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Morphic Holding's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Morphic Holding's stock. These opinions can provide insight into Morphic Holding's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Morphic Stock
If you are still planning to invest in Morphic Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Morphic Holding's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |